ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Ann Thorac Surg 2009;87:1532-1538. doi:10.1016/j.athoracsur.2009.02.069
© 2009 The Society of Thoracic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Sanjay Theodore
Phillip Antippa
James Tatoulis
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Theodore, S.
Right arrow Articles by Tatoulis, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Theodore, S.
Right arrow Articles by Tatoulis, J.
Related Collections
Right arrow Lung - other


Original Articles: General Thoracic

Surgical Management of Invasive Pulmonary Fungal Infection in Hematology Patients

Sanjay Theodore, MCha, Matthew Liava'a, MBChBa, Phillip Antippa, FRACSa,*, Rochelle Wynne, PhDa, Andrew Grigg, FRACPb, Monica Slavin, FRACPc, James Tatoulis, MD, FRACSa

a Department of Cardiothoracic Surgery, The Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
b Department of Haematology, The Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia
c Victorian Infectious Diseases Service, The Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia

Accepted for publication February 24, 2009.

* Address correspondence to Dr Antippa, Department of Cardiothoracic Surgery, Royal Melbourne Hospital, Victoria, 3052, Australia (Email: phillip.antippa{at}mh.org.au).

Background: The purpose of this study was to analyze our institutional results with pulmonary resection in neutropenic patients with hematologic malignancies and suspected invasive pulmonary fungal infections.

Methods: We performed a retrospective medical record review of 25 immunocompromised patients with hematologic malignancies who underwent pulmonary resection between 2000 and 2007. We analyzed preoperative diagnostic technique, degree of pulmonary resection, and postoperative morbidity and mortality to determine whether surgery is a viable treatment option in this subset of patients.

Results: Twenty-three of 25 patients had a minithoracotomy compared with 2 who had video-assisted thorascopic surgery resection only. Thirteen had wedge resections, 9 had lobectomies, and 3 had segmentectomies. Early surgical morbidity was 2 of 25, involving 1 pneumothorax and 1 empyema. In-hospital mortality was 2, with 1 death primarily related to surgery. Median survival was 342 days, and survival was significantly better in patients with only one lesion. No patient experienced late recurrence of invasive pulmonary fungal infection. Resected pulmonary tissue also provided the best chance for a proven diagnosis in 19 of 25 (76%).

Conclusions: This study confirms that pulmonary resection in high-risk immunocompromised patients with suspected invasive fungal infection can be carried out with excellent operative morbidity and mortality.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2009 by The Society of Thoracic Surgeons.